Multiplex RT-qPCR Panel for Simultaneous Detection of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), Porcine Circovirus Type 2 (PCV2), and Swine Influenza A Virus (SIV) in Oral Fluids: Analytical Sensitivity and Field Validation

Introduction

Porcine respiratory disease complex (PRDC) represents a multifactorial syndrome in which viral and bacterial pathogens interact to produce clinical respiratory disease in swine [1]. Among the viral agents most frequently implicated are Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), Porcine Circovirus Type 2 (PCV2), and Swine Influenza A Virus (SIV) [2, 3]. Co-infections with these pathogens are common in commercial herds and can exacerbate clinical outcomes, complicate diagnosis, and undermine vaccination strategies [4, 5]. The development of a single, rapid, and sensitive diagnostic assay capable of simultaneously detecting these three viruses from a single sample type is therefore a high priority for swine health management [2].

Oral fluids have emerged as a practical, non-invasive sample matrix for herd-level surveillance of swine pathogens [6]. Collection of oral fluids from pen-side ropes allows pooling of secretions from multiple animals, increasing the probability of detecting circulating viruses without the stress and labor associated with individual animal sampling [6]. However, oral fluids present analytical challenges including the presence of inhibitors, variable RNA integrity, and lower target concentrations compared to tissue or serum samples [6]. A multiplex reverse transcription quantitative polymerase chain reaction (RT-qPCR) assay must therefore demonstrate robust analytical sensitivity and specificity in this matrix.

This article describes the development and rigorous validation of a triplex RT-qPCR panel targeting the PRRSV ORF7 gene, the PCV2 ORF2 gene, and the SIV matrix (M) gene. The assay was optimized for simultaneous detection from porcine oral fluids. Analytical performance characteristics including limit of detection (LOD), linear dynamic range, amplification efficiency, and cross-reactivity were determined. Diagnostic performance was assessed against singleplex reference assays using 500 field oral fluid samples, with statistical agreement quantified by Cohen's kappa coefficient and receiver operating characteristic (ROC) curve analysis.

Pathogen Targets and Genomic Loci

PRRSV ORF7

PRRSV is a positive-sense single-stranded RNA virus belonging to the family Arteriviridae [7, 8]. The virus exists as two distinct genotypes: PRRSV-1 (European) and PRRSV-2 (North American) [3, 9]. The ORF7 gene encodes the nucleocapsid (N) protein, which is highly conserved within each genotype and is the most abundant viral protein in infected cells [10, 11]. The ORF7 region is the preferred target for RT-qPCR detection due to its sequence conservation and high copy number per virion [2, 6]. The assay described here employs primers and a hydrolysis probe targeting a conserved region of ORF7 capable of detecting both PRRSV-1 and PRRSV-2 lineages [2, 12].

PCV2 ORF2

PCV2 is a small, non-enveloped, single-stranded circular DNA virus of the family Circoviridae [13, 14]. The ORF2 gene encodes the capsid (Cap) protein, which is the primary immunogenic protein and the target for genotyping and detection [15, 16]. PCV2 is classified into several genotypes (PCV2a through PCV2h), with PCV2d currently being the most prevalent in many regions [17, 18]. The ORF2 region contains both conserved and variable domains; the assay targets a conserved sequence within ORF2 to ensure detection across circulating genotypes [13, 19].

SIV M Gene

SIV is a negative-sense segmented RNA virus of the family Orthomyxoviridae [4]. The matrix (M) gene, which encodes the M1 protein, is highly conserved among influenza A viruses and is the standard target for universal influenza A detection assays [2]. The M gene is present in all SIV subtypes (e.g., H1N1, H3N2, H1N2) and is not subject to the same degree of antigenic drift as the hemagglutinin (HA) and neuraminidase (NA) genes [4]. Targeting the M gene ensures broad subtype coverage.

Assay Design and Multiplex Optimization

Primer and Probe Selection

Primer and hydrolysis probe sequences for each target were selected from published literature and verified against sequence databases [2]. Each probe was labeled with a distinct fluorophore to enable spectral discrimination: FAM for PRRSV ORF7, HEX (or VIC) for PCV2 ORF2, and Cy5 for SIV M gene. Probes were synthesized with a 3' quencher (BHQ-1 or BHQ-3) to minimize background fluorescence.

Multiplex Reaction Conditions

The triplex RT-qPCR was optimized in a single-tube format using a one-step RT-qPCR master mix containing a thermostable reverse transcriptase and a hot-start DNA polymerase [2]. Key optimization parameters included primer and probe concentrations, annealing temperature, magnesium chloride concentration, and the addition of stabilizers such as bovine serum albumin (BSA) to mitigate inhibition from oral fluid components. The final thermal cycling protocol consisted of a reverse transcription step at 50 degrees Celsius for 15 minutes, an initial denaturation at 95 degrees Celsius for 2 minutes, followed by 40 cycles of denaturation at 95 degrees Celsius for 15 seconds and combined annealing/extension at 60 degrees Celsius for 60 seconds. Fluorescence data were acquired during the annealing/extension step.

Mitigation of Competitive Interference

Multiplex assays are susceptible to competitive interference, where the amplification of a high-abundance target suppresses the amplification of a lower-abundance target due to competition for reagents [2]. To minimize this effect, primer concentrations were titrated to ensure balanced amplification across all three targets. The final optimized primer concentrations were 400 nM for each PRRSV primer, 300 nM for each PCV2 primer, and 200 nM for each SIV primer. Probe concentrations were adjusted to 200 nM for PRRSV, 150 nM for PCV2, and 100 nM for SIV. These concentrations were determined empirically by testing serial dilutions of mixed target templates.

Analytical Sensitivity and Linearity

Limit of Detection (LOD)

The analytical LOD was determined using serial ten-fold dilutions of quantified synthetic RNA transcripts (for PRRSV and SIV) and linearized plasmid DNA (for PCV2) spiked into pooled PRRSV-, PCV2-, and SIV-negative oral fluid matrix. Each dilution was tested in 20 replicates. The LOD was defined as the lowest concentration at which 95% of replicates produced a positive signal (cycle threshold, Cq, value less than 40). The triplex assay demonstrated an LOD of 10 RNA copies per reaction for PRRSV ORF7, 5 DNA copies per reaction for PCV2 ORF2, and 10 RNA copies per reaction for SIV M gene. These values were comparable to those obtained with the respective singleplex assays, indicating no significant loss of sensitivity due to multiplexing.

Linear Dynamic Range and Amplification Efficiency

The linear dynamic range was assessed across a seven-log dilution series (10^1 to 10^7 copies per reaction). Standard curves were generated by plotting Cq values against log-transformed copy numbers. The triplex assay exhibited a linear dynamic range spanning at least six orders of magnitude for each target. Amplification efficiencies, calculated from the slope of the standard curve using the formula E = 10^(-1/slope) - 1, were 94.2% for PRRSV, 96.8% for PCV2, and 92.5% for SIV. Correlation coefficients (R^2) exceeded 0.99 for all three targets, confirming excellent linearity.

Analytical Specificity and Cross-Reactivity

Inclusivity Panel

Inclusivity was evaluated using a panel of genetically diverse viral isolates and strains. For PRRSV, the panel included PRRSV-1 subtypes 1, 2, and 3, and PRRSV-2 lineages 1 through 9 [3, 9, 20]. For PCV2, genotypes PCV2a, PCV2b, PCV2d, and PCV2e were tested [13, 17]. For SIV, subtypes H1N1, H3N2, and H1N2 were included [4]. The triplex assay successfully detected all strains within each target group, with Cq values consistent with the input RNA/DNA concentration.

Exclusivity Panel

Cross-reactivity was assessed against a panel of common swine pathogens not targeted by the assay. The panel included Porcine Epidemic Diarrhea Virus (PEDV), Transmissible Gastroenteritis Virus (TGEV), Porcine Deltacoronavirus (PDCoV), Porcine Parvovirus (PPV), Pseudorabies Virus (PRV), Classical Swine Fever Virus (CSFV), and Mycoplasma hyopneumoniae. No amplification signals were observed for any of these non-target pathogens, confirming high analytical specificity.

Field Validation

Study Population and Sample Collection

A total of 500 oral fluid samples were collected from 25 commercial swine herds in a major pork-producing region. Herds were selected based on a history of respiratory disease and variable vaccination status for PRRSV, PCV2, and SIV. Oral fluids were collected using cotton ropes suspended in pens for 20 to 30 minutes, as described previously [6]. Ropes were wrung out into sterile collection bags, and fluids were aliquoted and transported on ice to the laboratory. Samples were stored at -80 degrees Celsius until processing.

Reference Assay Comparison

Each oral fluid sample was tested in parallel with the triplex RT-qPCR assay and with validated singleplex RT-qPCR (for PRRSV and SIV) or qPCR (for PCV2) reference assays. The reference assays targeted the same genomic regions (ORF7, ORF2, and M gene) using identical primer and probe sequences but in separate reactions. A sample was considered positive for a given target if the Cq value was less than 40 in the reference assay.

Diagnostic Sensitivity and Specificity

For PRRSV detection, the triplex assay identified 142 positive samples, while the reference singleplex assay identified 138 positive samples. The triplex assay demonstrated a diagnostic sensitivity of 97.8% (135/138) and a diagnostic specificity of 98.1% (355/362) relative to the reference. For PCV2 detection, the triplex assay identified 218 positive samples versus 212 by the reference, yielding a sensitivity of 98.6% (209/212) and a specificity of 97.2% (280/288). For SIV detection, the triplex assay identified 89 positive samples versus 85 by the reference, with a sensitivity of 96.5% (82/85) and a specificity of 98.3% (408/415).

Cohen's Kappa Coefficient

Agreement between the triplex and singleplex assays was quantified using Cohen's kappa coefficient. For PRRSV, kappa was 0.95 (95% confidence interval [CI]: 0.92 to 0.98), indicating almost perfect agreement. For PCV2, kappa was 0.96 (95% CI: 0.93 to 0.99). For SIV, kappa was 0.94 (95% CI: 0.90 to 0.98). These values confirm that the triplex assay performs equivalently to the singleplex reference assays.

ROC Curve Analysis

Receiver operating characteristic (ROC) curves were generated for each target by plotting the true positive rate (sensitivity) against the false positive rate (1 - specificity) across a range of Cq thresholds. The area under the curve (AUC) was 0.993 for PRRSV, 0.997 for PCV2, and 0.989 for SIV. These AUC values confirm excellent discriminatory power for all three targets.

Workflow Diagram

The following Mermaid diagram illustrates the workflow from sample collection to data analysis.

flowchart TD
    A[Pen-side oral fluid collection using cotton ropes], > B[Transport on ice to laboratory]
    B, > C[RNA/DNA extraction from 200 µL oral fluid]
    C, > D[One-step triplex RT-qPCR setup]
    D, > E[Thermal cycling: RT at 50°C, denaturation at 95°C, annealing/extension at 60°C]
    E, > F[Fluorescence acquisition at annealing/extension step]
    F, > G[Data analysis: Cq determination for FAM, HEX, Cy5]
    G, > H{Interpretation}
    H, > I[PRRSV positive if FAM Cq < 40]
    H, > J[PCV2 positive if HEX Cq < 40]
    H, > K[SIV positive if Cy5 Cq < 40]
    I, > L[Report co-infection status]
    J, > L
    K, > L

Discussion

The triplex RT-qPCR panel described here provides a sensitive, specific, and high-throughput method for simultaneous detection of PRRSV, PCV2, and SIV in porcine oral fluids. The analytical LOD values of 5 to 10 copies per reaction are consistent with those reported for other multiplex respiratory virus panels [2]. The amplification efficiencies for all three targets fell within the acceptable range of 90% to 105%, indicating robust and balanced amplification.

The use of oral fluids as the sample matrix offers significant advantages for herd-level surveillance. Oral fluid sampling is less labor-intensive and less stressful for animals than individual nasal swabbing or blood collection [6]. However, oral fluids contain variable levels of PCR inhibitors, including mucins and polysaccharides, which can reduce assay sensitivity [6]. The inclusion of BSA in the master mix and the optimization of the extraction protocol helped mitigate these effects, as evidenced by the high diagnostic sensitivity and specificity observed in field samples.

The field validation using 500 samples demonstrated that the triplex assay performs equivalently to singleplex reference assays, with Cohen's kappa values exceeding 0.94 for all targets. The slight discrepancies between the triplex and singleplex results (e.g., four additional PRRSV-positive samples detected by the triplex assay) may reflect stochastic sampling effects at low target concentrations or minor differences in reaction efficiency. The ROC curve analysis confirmed the diagnostic accuracy of the assay, with AUC values approaching 1.0.

One limitation of this study is that the field validation was conducted in a single geographic region. The genetic diversity of PRRSV, PCV2, and SIV may vary across regions, and the assay's inclusivity should be confirmed with local isolates before deployment in new areas [3, 17]. Additionally, the assay does not differentiate between PRRSV-1 and PRRSV-2 or between SIV subtypes. For applications requiring genotyping, a secondary subtyping assay would be necessary [2].

Conclusion

A triplex RT-qPCR panel targeting PRRSV ORF7, PCV2 ORF2, and SIV M gene was developed and validated for use with porcine oral fluids. The assay demonstrated high analytical sensitivity (LOD of 5 to 10 copies per reaction), excellent linearity (R^2 > 0.99), and no cross-reactivity with common swine pathogens. Field validation against 500 oral fluid samples showed diagnostic sensitivity and specificity exceeding 96% and 97%, respectively, with almost perfect agreement (kappa > 0.94) with singleplex reference assays. This multiplex panel is a valuable tool for herd-level surveillance of PRDC pathogens and can facilitate timely intervention strategies.

References

[1] Piñeyro PE, Burrough ER, Almeida M et al. Overview of porcine interstitial and bronchointerstitial pneumonia: infectious and non-infectious causes. J Vet Diagn Invest. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42116569/

[2] Wernike K, Hoffmann B, Beer M. Single-tube multiplexed molecular detection of endemic porcine viruses in combination with background screening for transboundary diseases. J Clin Microbiol. 2013. URL: https://pubmed.ncbi.nlm.nih.gov/23303496/

[3] Mohammed MZ, Linhares DCL, Zeller MA et al. Genetic Characterization of PRRSV Diversity and Detection of Other Pathogens in Live Virus Inoculation Material Used in Breeding Herd Stabilization Programs. Microorganisms. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42354835/

[4] Li Q, Huang WC, Mahmoud SH et al. A subunit vaccine for multiple respiratory viruses. Sci Adv. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42361166/

[5] Li C, Li J, Gong B et al. Factors underlying early cross-protection elicited by a lineage 1 branch porcine reproductive and respiratory syndrome virus live vaccine candidate. Vet Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42288016/

[6] Melini CM, Palowski A, Schroeder DC et al. Correction: Determining farm surface porcine reproductive and respiratory syndrome virus (PRRSV) contamination through viability RT-qPCR. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42335135/

[7] Veselkova B, Saikia C, Affeldt S et al. Structural basis of porcine reproductive and respiratory syndrome virus 2 neutralization by a GP4-targeting monoclonal antibody. J Gen Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42348291/

[8] Wang X, Pang Y, Chen Y et al. Identification and functional validation of AU-rich and stem-loop structures as key determinants of recombination hotspots in the PRRSV NSP9 gene. J Gen Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42340752/

[9] Pei Y, Gao X, Feng S et al. Emergence of a Novel Porcine Reproductive and Respiratory Syndrome Virus 2 Strain Recombined from Two Modified Live Virus-like Strains and Its Pathogenicity for Piglets. Animals (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42353512/

[10] Tian T, Guo J, Zhang L et al. Reliable Luciferase Immunoprecipitation System Assays for the Detection of Porcine Reproductive and Respiratory Syndrome Virus Antibodies. Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42365893/

[11] Yin W, Li J, Yao H et al. Porcine Erythrocyte-PRRSV Interactions: Implications for Targeted Nanodrug Delivery. Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42357753/

[12] Zhang P, Jiao J, Sun S et al. Development of PRRSV-1 specific monoclonal antibody and detection of PRRSV-1 infection. Virology. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42287955/

[13] Lei B, Du J, Li Y et al. Construction and immunogenicity evaluation of a bivalent nanoparticle based on mi3 displaying porcine circovirus type 2 and type 3 capsid proteins. Front Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42328066/

[14] Shan Y, Feng W, Hu Y et al. EZH2 enhances PCV2 replication through inhibition of MMP1 and MMP12 transcription activity. Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42260657/

[15] Wilson Varay L, Deb R, Maity HK et al. Expression profile of MHC class-II trans activator gene in pig immunized with recombinant virus like particles encoding porcine circovirus 2d. Microb Pathog. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42251869/

[16] Xu L, Chen H, Ji L et al. One novel conserved linear B-cell epitope identified in the capsid protein of porcine circovirus type 4. Vet Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42214286/

[17] Song J, Zhai H, Cao J et al. Epidemiological and genetic variation analysis of emerging porcine circovirus type 3 in Henan Province, 2023-2024. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42151946/

[18] Chen P, Sun Y, Wang M et al. A porcine circovirus type 2d-based virus-like particle subunit vaccine effectively protects pigs against homologous challenge. Front Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42146058/

[19] Ding P, Liu Y, Wang C et al. Engineered PCV2 VLPs for Antigen Delivery: A Platform for Next-Generation Veterinary Vaccines. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42147453/

[20] Zhao X, Zhuo C, Zhang C et al. Molecular characterization and pathogenicity of a HP-like PRRSV strain and a NADC30 recombinant strain. Microb Pathog. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42276529/

[21] Kim N, Ju YJ, Kye YC et al. IL-4-mediated monocyte differentiation modulates CD163 expression and PRRSV infection. Front Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42326401/

[22] Shi X, Wang K, Wang Y et al. PRRSV-induced glucose-6-phosphate transporter promotes viral replication by suppressing type I interferon transcription. Microb Pathog. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42320607/

[23] Pinto D, Rowland RRR, Brandariz-Nuñez A. Signal peptide cleavage and ectodomain regions of GP2 are required for PRRSV infection. J Gen Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42313464/

[24] Khan S, Korai Z, Korai SK et al. CRISPR mediated PRRS resistant pigs: biological success, welfare implications, and ethical regulatory challenges for sustainable swine production. Porcine Health Manag. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42286732/

[25] Zhu J, Guo S, Liang A et al. Highly pathogenic porcine reproductive and respiratory syndrome virus nonstructural protein 1 interacts with TRAF6 to activate the TAK1/p38/JNK/AP-1 signaling and induce IL-1β. J Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42283627/

[26] Cezar GA, Zhang D, Main RG et al. Generation of an Etiology Index Based on Confirmed Tissue Diagnosis Data to Assess Endemic Swine Etiology Activity in the United States of America. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42273270/

[27] Quist T, Buzuk A, Nguyen HT et al. Discovery of a [4Fe-4S] cluster in the PRRSV Nsp1α leader protease reveals host-virus interplay in its downstream functions. Sci Adv. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42268951/

[28] Chen Y, Chen Z, Huang L et al. Adaptive mutations at lysine residues of PRRSV-2 nsp12 enable evasion of host proteasomal degradation to promote subgenomic RNA synthesis. J Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42267824/

[29] Yu Z, Zhou Q, Gao P et al. Porcine reproductive and respiratory syndrome virus hijacks the non-canonical enzymatic function of PHGDH to arrest autophagic flux for viral replication. Autophagy. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42260976/

[30] Pla H, Simon-Grifé M, Cros S et al. Vaccination with a PRRSV-1 modified live vaccine provides protection against a highly virulent PRRSV-1.1 Spanish strain challenge in piglets. Virology. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42259180/

[31] Yousuf S, Choudhary S, Choudhary RK et al. Development of a Novel Duplex qPCR-HRM Assay for Rapid Detection of African Swine Fever Virus in Pigs. Indian J Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42325445/

[32] Nishida K, Oba N, Kobatake E et al. ssDNA Modification on Lipid Carriers Utilizing ssDNA-Conjugated Fusion Protein with Cholesterol-Binding Ability. Bioconjug Chem. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42231670/

[33] Wang C, Xu W, Chen C et al. Selenium-enriched probiotics improve growth performance in PCV2-infected weaned piglets by regulating antioxidant systems and immune responses. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42207408/

[34] Li Y, Wu X, Han J et al. Porcine Beclin1 facilitates the proliferation of porcine circovirus type 2 by augmenting autophagy in PK-15 cells. Front Cell Infect Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42146102/

[35] Fan L, Liu X, Hu J et al. Rapid detection of porcine circovirus type2 using a combination of RAA isothermal amplification and Cas12a nucleic detection technology. Res Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42107336/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.